| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Nemerson Y | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Tissue factor and hemostasis | |
| P478 | volume | 71 |
| Q50913810 | 6-Methylsulfinylhexyl isothiocyanate modulates endothelial cell function and suppresses leukocyte adhesion. |
| Q36757518 | A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor |
| Q41027629 | A mathematical model of thrombin production in blood coagulation, Part I: The sparsely covered membrane case |
| Q34046930 | A microscopic model of enzyme kinetics |
| Q35219268 | Abruption-associated prematurity. |
| Q42836585 | Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides |
| Q73941498 | Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis |
| Q40342950 | Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model |
| Q33890331 | Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation |
| Q38783040 | Assessment and significance of protein-protein interactions during development of protein biopharmaceuticals. |
| Q41584328 | Attenuation of Multiple Organ Damage by Continuous Low-Dose Solvent-Free Infusions of Resveratrol after Severe Hemorrhagic Shock in Rats |
| Q33585249 | Biology of tissue factor pathway inhibitor. |
| Q36156442 | Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus. |
| Q28367869 | Blockade by ruthenium red of tissue factor-initiated coagulation |
| Q35793488 | CD40 ligation induces tissue factor expression in human vascular smooth muscle cells |
| Q38368526 | Cellular events in alveolitis and the evolution of pulmonary fibrosis |
| Q35847687 | Coagulation disorders of cardiopulmonary bypass: a review |
| Q42850803 | Coagulation factor VII and malignant progression of hepatocellular carcinoma |
| Q33895278 | Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis |
| Q34762864 | Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding |
| Q30663692 | Demonstration of the extrinsic coagulation pathway in teleostei: identification of zebrafish coagulation factor VII |
| Q37382356 | Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant |
| Q33214236 | Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity |
| Q38103820 | Drug-induced thrombosis: an update |
| Q52319754 | Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer. |
| Q33838757 | Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease |
| Q36243054 | Effect of tissue factor deficiency on mouse and tumor development |
| Q40006523 | Emerging roles for vascular smooth muscle cell exosomes in calcification and coagulation |
| Q35084705 | Endometriosis and tissue factor |
| Q35652150 | Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding |
| Q35352128 | Enhanced expression of monocyte tissue factor in patients with liver cirrhosis |
| Q39796241 | Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor |
| Q42158090 | Environments of the four tryptophans in the extracellular domain of human tissue factor: comparison of results from absorption and fluorescence difference spectra of tryptophan replacement mutants with the crystal structure of the wild-type protein. |
| Q35847531 | Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis |
| Q33785420 | Expression of tissue factor procoagulant activity: regulation by cytosolic calcium |
| Q41992252 | Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis |
| Q64075447 | Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications |
| Q38757815 | Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study. |
| Q34287997 | Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer |
| Q37193598 | Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling |
| Q35635143 | Fluid shear stress alters the hemostatic properties of endothelial outgrowth cells |
| Q36220317 | Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line |
| Q33822980 | Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor |
| Q40522551 | Hemostatic changes in patients with brain tumors |
| Q41834727 | Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol est |
| Q41767827 | Identification of a domain in apolipoprotein B-100 that inhibits the procoagulant activity of tissue factor |
| Q36374066 | Immuno-PET of tissue factor in pancreatic cancer |
| Q44394208 | Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies |
| Q35834222 | In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes |
| Q31920320 | In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy |
| Q36815173 | Increased monocyte tissue factor expression in coronary disease |
| Q77974386 | Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: the use of recombinant human tissue factor as an example |
| Q42832371 | Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor |
| Q24339425 | Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque |
| Q77470599 | Malignant gastrointestinal stromal tumor of the small intestine: rare complication of acute disseminated intravascular coagulation without hematogenous metastasis |
| Q37186763 | Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation |
| Q41873727 | Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells |
| Q38128286 | Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology |
| Q39398761 | Monoclonal antibody JC1: new reagent for studying cell proliferation |
| Q43085088 | Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. |
| Q28084934 | Natural Products for Antithrombosis |
| Q34027314 | Non-lipid-lowering effects of statins on atherosclerosis |
| Q33714186 | Novel therapies targeting endometriosis |
| Q38318856 | Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro |
| Q27023547 | On the origin of microparticles: From "platelet dust" to mediators of intercellular communication |
| Q28478187 | Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion |
| Q34549341 | Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. |
| Q92556952 | Platelets and Immune Responses During Thromboinflammation |
| Q34171376 | Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro |
| Q35798474 | Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface |
| Q43854356 | Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities |
| Q37517947 | Prognostic value of tissue factor in patients with abdominal aortic and iliac arterial aneurysms - preliminary study. |
| Q40690511 | Protein kinase C (PKC) dependent induction of tissue factor (TF) by mesangial cells in response to inflammatory mediators and release during apoptosis |
| Q41894159 | Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease |
| Q42687644 | Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization |
| Q34334154 | Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology |
| Q64949658 | Rhamnan sulfate extracted from Monostroma nitidum attenuates blood coagulation and inflammation of vascular endothelial cells. |
| Q42920423 | Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities |
| Q42138675 | Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. |
| Q91646395 | Sensitive and Specific Detection of Platelet-Derived and Tissue Factor-Positive Extracellular Vesicles in Plasma Using Solid-Phase Proximity Ligation Assay |
| Q42387360 | Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report |
| Q42809928 | Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides |
| Q34177305 | Structure and dynamics of zymogen human blood coagulation factor X |
| Q34046942 | Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface |
| Q33835572 | Targeted delivery of paclitaxel to tumor cells: synthesis and in vitro evaluation |
| Q37702117 | Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer |
| Q30453862 | Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer |
| Q36417960 | Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model |
| Q37129768 | The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. |
| Q33805135 | The importance of residues 195-206 of human blood clotting factor VII in the interaction of factor VII with tissue factor |
| Q40178266 | The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses |
| Q34481022 | The plasma hemostatic proteome: thrombin generation in healthy individuals |
| Q47773950 | The regulation of uterine tissue factor by estrogen |
| Q51692622 | The relationship between gender and age with monocyte tissue factor expression. |
| Q36467563 | The role of RAS in the pathogenesis of preeclampsia |
| Q33728350 | The role of tissue factor and factor VIIa in hemostasis |
| Q34360277 | The tissue factor requirement in blood coagulation |
| Q60584701 | Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases |
| Q28246124 | Thrombin and vascular inflammation |
| Q35166472 | Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation |
| Q34469944 | Thrombin generation profiles in deep venous thrombosis |
| Q89767304 | Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer |
| Q36565603 | Tissue factor as a novel target for treatment of breast cancer |
| Q35477714 | Tissue factor as a tumor procoagulant |
| Q34186249 | Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice |
| Q36540595 | Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection |
| Q37374280 | Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation |
| Q33900126 | Tissue factor is rapidly induced in arterial smooth muscle after balloon injury |
| Q33956786 | Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation |
| Q35287011 | Tissue factor-dependent chemokine production aggravates experimental colitis. |
| Q37211735 | Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma |
| Q33751548 | Transcriptional regulation of endothelial cell tissue factor expression during Rickettsia rickettsii infection: involvement of the transcription factor NF-kappaB |
| Q34755104 | Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases. |
| Q35752422 | Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure |
| Q34018527 | Use of an oriented transmembrane protein to probe the assembly of a supported phospholipid bilayer |
| Q36222474 | Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody |
| Q50291178 | factor X -> factor Xa + factor X activation peptide (TF:F7 catalyst) |
| Q28276433 | p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor |
Search more.